Microneedle-based Transdermal Sensing of Electrolytes: Towards A Metabolic Panel-
Award amount
$600,000Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Biolinq Incorporated
- Proposal award date
- 2014-08-01
- Contract end date
- 2016-07-31
- UEI
- GW6NF3RJFSH8
- Solicitation number
- PA11-335
- Topic code
- 200
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes
- A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability
- A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability
- Wearable Biosensors for Real time Blood Alcohol Monitoring
- Wearable Biosensors for Real-time Blood Alcohol Monitoring
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
- Next-Gen Oral Therapeutics for Type 2 Diabetes
- Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
- Development of novel therapeutics for obesity and type 2 diabetes
- Metrifonate local application for DFU treatment
Research funding history
7 SBIR/STTR records share this UEI (2014–2025). Reported award amounts total $4,907,636. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services